87
Views
0
CrossRef citations to date
0
Altmetric
Review

PCR diagnostic platforms for non-Aspergillus mold infections: ready for routine implementation in the clinic?

&
Pages 273-282 | Received 02 Nov 2023, Accepted 29 Feb 2024, Published online: 19 Mar 2024

References

  • Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database. Clin Infect Dis. 2010;50(8):1091–1100. doi: 10.1086/651263
  • Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50(8):1101–1111. doi: 10.1086/651262
  • Lamoth F, Kontoyiannis DP. Therapeutic challenges of non-aspergillus invasive mold infections in immunosuppressed patients. Antimicrob Agents Chemother. 2019;63(11). doi: 10.1128/AAC.01244-19
  • Lamoth F. Novel approaches in the management of Mucormycosis. Curr Fungal Infect R. 2023;17(2):98–107. doi: 10.1007/s12281-023-00463-3
  • Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20(4):695–704. doi: 10.1128/CMR.00014-07
  • Seidel D, Meissner A, Lackner M, et al. Prognostic factors in 264 adults with invasive scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope((R)). Crit Rev Microbiol. 2019;45(1):1–21. doi: 10.1080/1040841X.2018.1514366
  • Delliere S, Guitard J, Sabou M, et al. Detection of circulating DNA for the diagnosis of invasive fusariosis: retrospective analysis of 15 proven cases. Med Mycol. 2022;60(9). doi: 10.1093/mmy/myac049
  • Nucci M, Carlesse F, Cappellano P, et al. Earlier diagnosis of invasive fusariosis with aspergillus serum galactomannan testing. PLoS One. 2014;9(1):e87784. doi: 10.1371/journal.pone.0087784
  • Lamoth F, Akan H, Andes D, et al. Assessment of the role of 1,3-beta-d-glucan testing for the diagnosis of invasive fungal infections in adults. Clin Infect Dis. 2021;72(Suppl 2):S102–S108. doi: 10.1093/cid/ciaa1943
  • Lamoth F, Nucci M, Fernandez-Cruz A, et al. Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis. Med Mycol. 2023;61(7). doi: 10.1093/mmy/myad061
  • Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008;47(4):503–509. doi: 10.1086/590004
  • White PL, Alanio A, Brown L, et al. An overview of using fungal DNA for the diagnosis of invasive mycoses. Expert Rev Mol Diagn. 2022;22(2):169–184. doi: 10.1080/14737159.2022.2037423
  • Gomes MZ, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev. 2011;24(2):411–445. doi: 10.1128/CMR.00056-10
  • Kyvernitakis A, Torres HA, Jiang Y, et al. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis. Clin Microbiol Infect. 2016;22(9):e811 811–e811 818. doi: 10.1016/j.cmi.2016.03.029
  • Lanternier F, Dannaoui E, Morizot G, et al. A global analysis of mucormycosis in France: the RetroZygo study (2005-2007). Clin Infect Dis. 2012;54 Suppl 1:S35–43.
  • Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) working group on zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17(12):1859–1867. doi: 10.1111/j.1469-0691.2010.03456.x
  • Walsh TJ, Hospenthal DR, Petraitis V, et al. Necrotizing mucormycosis of wounds following combat injuries, natural disasters, burns, and other trauma. J Fungi. 2019;5(3):57. doi: 10.3390/jof5030057
  • Lamoth F, Alexander BD. Nonmolecular methods for the diagnosis of respiratory fungal infections. Clin Lab Med. 2014;34(2):315–336. doi: 10.1016/j.cll.2014.02.006
  • Bernal-Martinez L, Buitrago MJ, Castelli MV, et al. Development of a single tube multiplex real-time PCR to detect the most clinically relevant mucormycetes species. Clin Microbiol Infect. 2013;19(1):E1–E7. doi: 10.1111/j.1469-0691.2012.03976.x
  • Bialek R, Konrad F, Kern J, et al. PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue. J Clin Pathol. 2005;58(11):1180–1184. doi: 10.1136/jcp.2004.024703
  • Gholinejad-Ghadi N, Shokohi T, Seifi Z, et al. Identification of mucorales in patients with proven invasive mucormycosis by polymerase chain reaction in tissue samples. Mycoses. 2018;61(12):909–915. doi: 10.1111/myc.12837
  • Hammond SP, Bialek R, Milner DA, et al. Molecular methods to improve diagnosis and identification of mucormycosis. J Clin Microbiol. 2011;49(6):2151–2153. doi: 10.1128/JCM.00256-11
  • Hata DJ, Buckwalter SP, Pritt BS, et al. Real-time PCR method for detection of zygomycetes. J Clin Microbiol. 2008;46(7):2353–2358. doi: 10.1128/JCM.02331-07
  • Hrncirova K, Lengerova M, Kocmanova I, et al. Rapid detection and identification of mucormycetes from culture and tissue samples by use of high-resolution melt analysis. J Clin Microbiol. 2010;48(9):3392–3394. doi: 10.1128/JCM.01109-10
  • Jillwin J, Rudramurthy SM, Singh S, et al. Molecular identification of pathogenic fungi in formalin-fixed and paraffin-embedded tissues. J Med Microbiol. 2021;70(2). doi: 10.1099/jmm.0.001282
  • Kasai M, Harrington SM, Francesconi A, et al. Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. J Clin Microbiol. 2008;46(11):3690–3702. doi: 10.1128/JCM.00917-08
  • Lengerova M, Racil Z, Hrncirova K, et al. Rapid detection and identification of mucormycetes in bronchoalveolar lavage samples from immunocompromised patients with pulmonary infiltrates by use of high-resolution melt analysis. J Clin Microbiol. 2014;52(8):2824–2828. doi: 10.1128/JCM.00637-14
  • Millon L, Larosa F, Lepiller Q, et al. Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. Clin Infect Dis. 2013;56(10):e95–101. doi: 10.1093/cid/cit094
  • Rickerts V, Just-Nubling G, Konrad F, et al. Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples. Eur J Clin Microbiol Infect Dis. 2006;25(1):8–13. doi: 10.1007/s10096-005-0078-7
  • Springer J, Goldenberger D, Schmidt F, et al. Development and application of two independent real-time PCR assays to detect clinically relevant mucorales species. J Med Microbiol. 2016;65(3):227–234. doi: 10.1099/jmm.0.000218
  • Voigt K, Cigelnik E, O’Donnell K. Phylogeny and PCR identification of clinically important zygomycetes based on nuclear ribosomal-DNA sequence data. J Clin Microbiol. 1999;37(12):3957–3964. doi: 10.1128/JCM.37.12.3957-3964.1999
  • Millon L, Scherer E, Rocchi S, et al. Molecular strategies to diagnose mucormycosis. J Fungi. 2019;5(1):24. doi: 10.3390/jof5010024
  • Hoffmann K, Pawlowska J, Walther G, et al. The family structure of the mucorales: a synoptic revision based on comprehensive multigene-genealogies. Persoonia. 2013;30(1):57–76. doi: 10.3767/003158513X666259
  • Baldin C, Soliman SSM, Jeon HH, et al. PCR-Based approach targeting mucorales-specific gene family for diagnosis of Mucormycosis. J Clin Microbiol. 2018;56(10). doi: 10.1128/JCM.00746-18
  • Lockhart SR, Bialek R, Kibbler CC, et al. Molecular techniques for genus and species determination of fungi from fresh and paraffin-embedded formalin-fixed tissue in the revised EORTC/MSGERC definitions of invasive fungal infection. Clin Infect Dis. 2021;72(Suppl 2):S109–S113. doi: 10.1093/cid/ciaa1836
  • Coste A, Conrad A, Porcher R, et al. Improving diagnosis of pulmonary mucormycosis: leads from a contemporary national study of 114 cases. Chest. 2023;164(5):1097–1107. doi: 10.1016/j.chest.2023.06.039
  • Bellanger AP, Berceanu A, Rocchi S, et al. Development of a quantitative PCR detecting cunninghamella bertholletiae to help in diagnosing this rare and aggressive mucormycosis. Bone Marrow Transplant. 2018;53(9):1180–1183. doi: 10.1038/s41409-018-0194-5
  • Caillot D, Valot S, Lafon I, et al. Is it time to include CT “Reverse Halo Sign” and qPCR targeting mucorales in serum to EORTC-MSG criteria for the diagnosis of pulmonary mucormycosis in leukemia patients? Open Forum Infect Dis. 2016;3(4):ofw190. doi: 10.1093/ofid/ofw190
  • Millon L, Caillot D, Berceanu A, et al. Evaluation of serum mucorales polymerase chain reaction (PCR) for the diagnosis of mucormycoses: the MODIMUCOR prospective trial. Clin Infect Dis. 2022;75(5):777–785. doi: 10.1093/cid/ciab1066
  • Millon L, Herbrecht R, Grenouillet F, et al. Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the french surveillance network of invasive fungal infections (RESSIF). Clin Microbiol Infect. 2016;22(9):e810 811–e810 818. doi: 10.1016/j.cmi.2015.12.006
  • Legrand M, Gits-Muselli M, Boutin L, et al. Detection of circulating mucorales DNA in critically Ill burn patients: preliminary report of a screening strategy for early diagnosis and treatment. Clin Infect Dis. 2016;63(10):1312–1317. doi: 10.1093/cid/ciw563
  • Springer J, Lackner M, Ensinger C, et al. Clinical evaluation of a mucorales-specific real-time PCR assay in tissue and serum samples. J Med Microbiol. 2016;65(12):1414–1421. doi: 10.1099/jmm.0.000375
  • Rocchi S, Scherer E, Mengoli C, et al. Interlaboratory evaluation of mucorales PCR assays for testing serum specimens: a study by the fungal PCR initiative and the modimucor study group. Med Mycol. 2021;59(2):126–138. doi: 10.1093/mmy/myaa036
  • Mercier T, Reynders M, Beuselinck K, et al. Serial detection of circulating mucorales DNA in invasive mucormycosis: a retrospective multicenter evaluation. J Fungi. 2019;5(4):113. doi: 10.3390/jof5040113
  • Ghelfenstein-Ferreira T, Verdurme L, Alanio A. Analytical performance of the commercial MucorGenius® assay as compared to an In-house qPCR assay to detect mucorales DNA in serum specimens. J Fungi. 2022;8(8):786. doi: 10.3390/jof8080786
  • Imbert S, Portejoie L, Pfister E, et al. A multiplex PCR and DNA-Sequencing workflow on serum for the diagnosis and species identification for invasive aspergillosis and Mucormycosis. J Clin Microbiol. 2023;61(1):e0140922. doi: 10.1128/jcm.01409-22
  • Lamoth F, Calandra T. Pulmonary aspergillosis: diagnosis and treatment. Eur Respir Rev. 2022;31(166):220114. doi: 10.1183/16000617.0114-2022
  • Scherer E, Iriart X, Bellanger AP, et al. Quantitative PCR (qPCR) detection of mucorales DNA in bronchoalveolar lavage fluid to diagnose pulmonary mucormycosis. J Clin Microbiol. 2018;56(8). doi: 10.1128/JCM.00289-18
  • Guegan H, Iriart X, Bougnoux ME, et al. Evaluation of MucorGenius(R) mucorales PCR assay for the diagnosis of pulmonary mucormycosis. J Infect. 2020;81(2):311–317. doi: 10.1016/j.jinf.2020.05.051
  • Wehrle-Wieland E, Affolter K, Goldenberger D, et al. Diagnosis of invasive mold diseases in patients with hematological malignancies using aspergillus, mucorales, and panfungal PCR in BAL. Transpl Infect Dis. 2018;20(5):e12953. doi: 10.1111/tid.12953
  • Springer J, White PL, Kessel J, et al. A comparison of aspergillus and mucorales PCR testing of different bronchoalveolar lavage fluid fractions from patients with suspected invasive pulmonary fungal disease. J Clin Microbiol. 2018;56(2). doi: 10.1128/JCM.01655-17
  • Lau A, Chen S, Sorrell T, et al. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J Clin Microbiol. 2007;45(2):380–385. doi: 10.1128/JCM.01862-06
  • Rickerts V, Mousset S, Lambrecht E, et al. Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens. Clin Infect Dis. 2007;44(8):1078–1083. doi: 10.1086/512812
  • Zaman K, Rudramurthy SM, Das A, et al. Molecular diagnosis of rhino-orbito-cerebral mucormycosis from fresh tissue samples. J Med Microbiol. 2017;66(8):1124–1129. doi: 10.1099/jmm.0.000560
  • Alanio A, Garcia-Hermoso D, Mercier-Delarue S, et al. Molecular identification of mucorales in human tissues: contribution of PCR electrospray-ionization mass spectrometry. Clin Microbiol Infect. 2015;21(6):594 e591–595. doi: 10.1016/j.cmi.2015.01.017
  • Pandey M, Sachdev J, Yadav RK, et al. Utility of in-house and commercial PCR assay in diagnosis of covid-19 associated mucormycoss in an emergency setting in a tertiary care center. J Med Microbiol. 2023;72(8). doi: 10.1099/jmm.0.001754
  • Rickerts V. Identification of fungal pathogens in formalin-fixed, paraffin-embedded tissue samples by molecular methods. Fungal Biol. 2016;120(2):279–287. doi: 10.1016/j.funbio.2015.07.002
  • Rickerts V, Khot PD, Ko DL, et al. Enhanced fungal DNA-extraction from formalin-fixed, paraffin-embedded tissue specimens by application of thermal energy. Med Mycol. 2012;50(6):667–672. doi: 10.3109/13693786.2012.665613
  • Sabino R, Wiederhold N. Diagnosis from tissue: histology and identification. J Fungi. 2022;8(5):505. doi: 10.3390/jof8050505
  • Nucci M, Anaissie E, Forrest GN. Invasive fusariosis. Clin Microbiol Rev. 2023;36(4):e0015922. doi: 10.1128/cmr.00159-22
  • Matsuo T, Wurster S, Jiang Y, et al. Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes. J Antimicrob Chemother. 2023;79(2):297–306. doi: 10.1093/jac/dkad377
  • Ahmad S, Khan ZU, Theyyathel AM. Development of a nested PCR assay for the detection of Fusarium solani DNA and its evaluation in the diagnosis of invasive fusariosis using an experimental mouse model. Mycoses. 2010;53(1):40–47. doi: 10.1111/j.1439-0507.2008.01657.x
  • Bernal-Martinez L, Buitrago MJ, Castelli MV, et al. Detection of invasive infection caused by Fusarium solani and non-Fusarium solani species using a duplex quantitative PCR-based assay in a murine model of fusariosis. Med Mycol. 2012;50(3):270–275. doi: 10.3109/13693786.2011.604047
  • Hue FX, Huerre M, Rouffault MA, et al. Specific detection of fusarium species in blood and tissues by a PCR technique. J Clin Microbiol. 1999;37(8):2434–2438. doi: 10.1128/JCM.37.8.2434-2438.1999
  • Khan ZU, Ahmad S, Theyyathel AM. Diagnostic value of DNA and (1–>3)- beta-D-glucan detection in serum and bronchoalveolar lavage of mice experimentally infected with fusarium oxysporum. J Med Microbiol. 2008;57(Pt 1):36–42. doi: 10.1099/jmm.0.47301-0
  • Muraosa Y, Schreiber AZ, Trabasso P, et al. Development of cycling probe-based real-time PCR system to detect fusarium species and Fusarium solani species complex (FSSC). Int J Med Microbiol. 2014;304(3–4):505–511. doi: 10.1016/j.ijmm.2014.03.001
  • Springer J, Walther G, Rickerts V, et al. Detection of Fusarium species in clinical specimens by probe-based real-time PCR. J Fungi. 2019;5(4):105. doi: 10.3390/jof5040105
  • Dornbusch HJ, Buzina W, Summerbell RC, et al. Fusarium verticillioides abscess of the nasal septum in an immunosuppressed child: case report and identification of the morphologically atypical fungal strain. J Clin Microbiol. 2005;43(4):1998–2001. doi: 10.1128/JCM.43.4.1998-2001.2004
  • Healy M, Reece K, Walton D, et al. Use of the diversi lab system for species and strain differentiation of fusarium species isolates. J Clin Microbiol. 2005;43(10):5278–5280. doi: 10.1128/JCM.43.10.5278-5280.2005
  • Ramirez-Garcia A, Pellon A, Rementeria A, et al. Scedosporium and Lomentospora: an updated overview of underrated opportunists. Med Mycol. 2018;56(suppl_1):102–125. doi: 10.1093/mmy/myx113
  • Slavin M, van Hal S, Sorrell TC, et al. Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality. Clin Microbiol Infect. 2015;21(5):490 e491–410. doi: 10.1016/j.cmi.2014.12.021
  • Harun A, Blyth CC, Gilgado F, et al. Development and validation of a multiplex PCR for detection of scedosporium spp. In respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol. 2011;49(4):1508–1512. doi: 10.1128/JCM.01810-10
  • Castelli MV, Buitrago MJ, Bernal-Martinez L, et al. Development and validation of a quantitative PCR assay for diagnosis of scedosporiosis. J Clin Microbiol. 2008;46(10):3412–3416. doi: 10.1128/JCM.00046-08
  • Buelow DR, Gu Z, Walsh TJ, et al. Evaluation of multiplexed PCR and liquid-phase array for identification of respiratory fungal pathogens. Med Mycol. 2012;50(7):775–780. doi: 10.3109/13693786.2012.666681
  • Babouee Flury B, Weisser M, Prince SS, et al. Performances of two different panfungal PCRs to detect mould DNA in formalin-fixed paraffin-embedded tissue: what are the limiting factors? BMC Infect Dis. 2014;14(692). doi: 10.1186/s12879-014-0692-z
  • Buitrago MJ, Aguado JM, Ballen A, et al. Efficacy of DNA amplification in tissue biopsy samples to improve the detection of invasive fungal disease. Clin Microbiol Infect. 2013;19(6):E271–277. doi: 10.1111/1469-0691.12110
  • Ala-Houhala M, Koukila-Kahkola P, Antikainen J, et al. Clinical use of fungal PCR from deep tissue samples in the diagnosis of invasive fungal diseases: a retrospective observational study. Clin Microbiol Infect. 2018;24(3):301–305. doi: 10.1016/j.cmi.2017.08.017
  • Gomez CA, Budvytiene I, Zemek AJ, et al. Performance of targeted fungal sequencing for culture-Independent diagnosis of invasive fungal disease. Clin Infect Dis. 2017;65(12):2035–2041. doi: 10.1093/cid/cix728
  • Rahn S, Schuck A, Kondakci M, et al. A novel comprehensive set of fungal real time PCR assays (fuPCR) for the detection of fungi in immunocompromised haematological patients-A pilot study. Int J Med Microbiol. 2016;306(8):611–623. doi: 10.1016/j.ijmm.2016.10.003
  • Scharf S, Bartels A, Kondakci M, et al. fuPCR as diagnostic method for the detection of rare fungal pathogens, such as Trichosporon, Cryptococcus and Fusarium. Med Mycol. 2021;59(11):1101–1113. doi: 10.1093/mmy/myab045
  • Jia B, Lovari R, Miller H, et al. Evaluation of a PCR-electrospray ionization mass spectrometry platform for detection and identification of fungal pathogens directly from prospectively collected bronchoalveolar lavage specimens. Diagn Microbiol Infect Dis. 2020;97(1):114988. doi: 10.1016/j.diagmicrobio.2020.114988
  • Massire C, Buelow DR, Zhang SX, et al. PCR followed by electrospray ionization mass spectrometry for broad-range identification of fungal pathogens. J Clin Microbiol. 2013;51(3):959–966. doi: 10.1128/JCM.02621-12
  • Shin JH, Ranken R, Sefers SE, et al. Detection, identification, and distribution of fungi in bronchoalveolar lavage specimens by use of multilocus PCR coupled with electrospray ionization/mass spectrometry. J Clin Microbiol. 2013;51(1):136–141. doi: 10.1128/JCM.01907-12
  • De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813–1821. doi: 10.1086/588660
  • Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2020;71(6):1367–1376. doi: 10.1093/cid/ciz1008
  • Lamoth F, Chung SJ, Damonti L, et al. Changing epidemiology of invasive mold infections in patients receiving azole prophylaxis. Clin Infect Dis. 2017;64(11):1619–1621. doi: 10.1093/cid/cix130
  • Pal R, Singh B, Bhadada SK, et al. COVID-19-associated mucormycosis: an updated systematic review of literature. Mycoses. 2021;64(12):1452–1459. doi: 10.1111/myc.13338
  • Zacharioudakis IM, Zervou FN, Mylonakis E. T2 magnetic resonance assay: overview of available data and clinical implications. J Fungi. 2018;4(2):45. doi: 10.3390/jof4020045
  • Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, et al. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015;60(6):892–899. doi: 10.1093/cid/ciu959
  • Jenks JD, White PL, Kidd SE, et al. An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections. Expert Rev Mol Diagn. 2023;23(12):1135–1152. doi: 10.1080/14737159.2023.2267977:1-18
  • Krifors A, Ozenci V, Ullberg M, et al. PCR with electrospray ionization-mass spectrometry on bronchoalveolar lavage for detection of invasive mold infections in hematological patients. PloS One. 2019;14(2):e0212812. doi: 10.1371/journal.pone.0212812
  • Pandey M, Xess I, Sachdev J, et al. Development of a sensitive and specific novel qPCR assay for simultaneous detection and differentiation of mucormycosis and aspergillosis by melting curve analysis. Front Fungal Biol. 2021;2(800898). doi: 10.3389/ffunb.2021.800898
  • Blauwkamp TA, Thair S, Rosen MJ, et al. Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease. Nat Microbiol. 2019;4(4):663–674. doi: 10.1038/s41564-018-0349-6
  • Armstrong AE, Rossoff J, Hollemon D, et al. Cell-free DNA next-generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease. Pediatr Blood Cancer. 2019;66(7):e27734. doi: 10.1002/pbc.27734
  • Bergin SP, Chemaly RF, Dadwal SS, et al. Plasma microbial cell-free DNA sequencing in immunocompromised patients with pneumonia: a prospective observational study. Clin Infect Dis. 2023. doi: 10.1093/cid/ciad599
  • Hogan CA, Yang S, Garner OB, et al. Clinical impact of metagenomic next-generation sequencing of plasma cell-free DNA for the diagnosis of infectious diseases: a multicenter retrospective cohort study. Clin Infect Dis. 2021;72(2):239–245. doi: 10.1093/cid/ciaa035
  • Hong DK, Blauwkamp TA, Kertesz M, et al. Liquid biopsy for infectious diseases: sequencing of cell-free plasma to detect pathogen DNA in patients with invasive fungal disease. Diagn Microbiol Infect Dis. 2018;92(3):210–213. doi: 10.1016/j.diagmicrobio.2018.06.009
  • Vissichelli NC, Morales MK, Kolipakkam B, et al. Cell-free next-generation sequencing impacts diagnosis and antimicrobial therapy in immunocompromised hosts: a retrospective study. Transpl Infect Dis. 2023;25(1):e13954. doi: 10.1111/tid.13954
  • Wang W, Yao Y, Li X, et al. Clinical impact of metagenomic next-generation sequencing of peripheral blood for the diagnosis of invasive mucormycosis: a single-center retrospective study. Microbiol Spectr. 2023;12(1). doi: 10.1128/spectrum.03553-23:e0355323
  • Xie Y, Li H, Chen F, et al. Clustered regularly interspaced short palindromic repeats-based microfluidic system in infectious diseases diagnosis: Current status, challenges, and perspectives. Adv Sci (Weinh). 2022;9(34):e2204172. doi: 10.1002/advs.202204172
  • Njiru ZK, Büscher P. Loop-mediated isothermal amplification technology: towards point of care diagnostics. PloS Negl Trop Dis. 2012;6(6):e1572. doi: 10.1371/journal.pntd.0001572
  • Tang Q, Tian S, Yu N, et al. Development and evaluation of a loop-mediated isothermal amplification method for rapid detection of aspergillus fumigatus. J Clin Microbiol. 2016;54(4):950–955. doi: 10.1128/JCM.01751-15
  • Springer J, White PL, Hamilton S, et al. Comparison of performance characteristics of aspergillus PCR in testing a range of blood-based samples in accordance with international methodological recommendations. J Clin Microbiol. 2016;54(3):705–711. doi: 10.1128/JCM.02814-15

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.